Australia's ECS Botanics rises on upbeat annual outlook
16/05/2025 03:15
** Shares of ECS Botanics Holdings ECS.AX rise 22.2% to A$0.011, set for their strongest trading session since late-August 2024, if gains hold ** The medical cannabis cultivator expects to exceed production for fiscal 2025 by 50% from FY24 levels ** More than 6.9 million shares change hands, 4.1 times the 30-day average volume ** Stock down 47.1% YTD, including current session's moves (Reporting by Nikita Maria Jino in Bengaluru) ((Nikita.Jino@thomsonreuters.com;))
Recent news on ECS Botanics Holdings
See all newsBrief: ECS Botanics Launches UK Branded Portfolio With Curaleaf
Brief: Ecs Botanics Holdings Posts FY Net Loss Attributable A$1.9 Million
Brief: ECS Botanics Logs Unaudited FY26 Revenue About A$21 Million
Brief: ECS Botanics Enters German Distribution Partnership With Nimbus Health
Brief: Ecs Botanics Says Quarterly Revenue Broadly Flat QoQ At A$5.65 Million